Top Banner
Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003
40

Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Jan 05, 2016

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Physical Activity and Weight Management

Julie Hagel, Pharm.D.

September 24, 2003

Page 2: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

U.S. Obesity Statistics

127 million adults: overweight or obese 2nd leading cause of preventable death Responsible for 5-7% of annual national

health care expenditure $117 billion in healthcare costs:

includes direct and indirect costs

Page 3: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

U.S. Obesity Statistics

43.6% women, 28.8% men attempt weight loss

$30 billion spent annually on weight loss products

Page 4: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

A need and an opportunity

National Institutes of Health (NIH) notes that few healthcare

providers play a role in management of

obesity

Page 5: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Barrier or Benefit?

No 3rd-party coverage

Who has time / space?

Scope of practice? Costs Competition

Page 6: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Pathophysiology of Obesity

Chronic medical condition Energy intake exceeds energy

expenditure Factors involved

Genetic and physiological Environmental Cultural and socioeconomic

Page 7: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Health Consequences of Obesity

Hypertension Dyslipidemias Type 2 diabetes Cardiovascular

disease Stroke Gallstones

Degenerative joint disease

Sleep apnea Respiratory disease Some types of

cancer Hyperuricemia/gout

Page 8: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Getting started……

NHLBI Obesity Education Initiative Treatment of overweight or obese person

is two step process Assessment Management

Requires lifelong effort!

Page 9: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Assessment:Weight & Obesity

Body Mass Index (BMI) Waist circumference Risk factors Readiness to lose weight

Page 10: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Assessment: BMI

Body Mass Index:

Wt in Kg

Ht in meters squared

or

Weight in Lb x 703

Ht in inches squared

BMI

Page 11: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

BMI Ranges

Normal: 18.5 to 24.9 Overweight: 25.0 to 29.9 Class I obesity: 30.0 to 34.9 Class II obesity: 35.0 to 39.9 Class III obesity: 40.0 or greater

(extreme obesity)

Page 12: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Assessment: Waist Circumference

Regardless of weight or calculated BMI, waist circumference marks increased risk Men: >40 inches Women: >35 inches

Measure right above the upper hip bone at the top of the iliac crest with tape measure parallel to floor

Page 13: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Fat Distribution

Apple Android shape, typically in males Fat store seen in abdomen

Pear Gynecoid shape, typically in females Fat store seen in buttocks, hips, thighs

Page 14: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Assessment: Risk Factors

Very high absolute risk Established coronary heart disease Other atherosclerotic diseases Type 2 diabetes Sleep apnea

Increased risk Osteoarthritis, gallstones, stress

incontinence, gynecological abnormalities

Page 15: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Assessment: Risk Factors

High absolute risk if three or more of the following: Hypertension Cigarette smoking High LDL cholesterol Low HDL cholesterol Impaired fasting glucose Family history of early cardiovascular disease Age

Male > 45 Female > 55

Page 16: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Assessment: Readiness

Motivation Previous attempts Potential barriers Support system

Page 17: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Assessment: Tools

Scale and Height measurement

Calculator or Chart On-line calculator

(Search engine: “BMI Calculator”)

Tape measure

Page 18: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Weighing In

Can be performed by patient for self- monitoring Recommend once weekly

Scale in pharmacy Document patient progress

Page 19: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Body Fat Analysis

Normal range Men: 12-15% (>25% indicator for obesity) Women: 20-25% (>30% indicator for obesity)

Measuring techniques Hydrostatic weighing- mainly used in research Bioimpedance Near-infrared spectroscopy Body fat calipers

Page 20: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Management

Goals Reduce and maintain body weight Prevent future weight gain Promote healthy lifestyle

Page 21: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Therapies

Must be individualized Can include:

Dietary therapy Physical activity Behavior therapy Combination of above Pharmacotherapy-eligible high risk patients Surgery- extreme obesity

Page 22: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

It doesn’t happen overnight….

NHLBI guidelines Initial goal: 10 percent reduction in body

weight Weight should be lost at rate of 1-2 pounds

per week

Consequences associated with losing weight too fast

Page 23: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Dietary Therapy

Modify diet to achieve a decrease is caloric intake

Must adopt long term nutritional adjustments

Avoid very low calorie (<800 kcal /day) content diets

Ensure that all daily recommended dietary allowances are met

Page 24: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Key Counseling Points

Learn energy values of different foods Read and understand nutrition labels Monitor food consumption

Reduce portion size Use dietary recall or food diary

Use new habits with food purchasing and preparation

Page 25: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Physical Activity

Has direct and indirect benefits Crucial for weight maintenance Evaluation before starting Recommendation is 60 minutes of

moderate intensity most days of week Build activity level slowly over period of

time

Page 26: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Key Counseling Points

Keep track of physical activity and chart weekly progress

Effects of increased activity add up; small increases = benefit

Step counters may help motivate Reduce sedentary time Build physical activity into each day

Page 27: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Behavior Therapy

Strategies to provide tools for overcoming barriers Consider attitude and past history Develop partnership with patient Set realistic goals

Page 28: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Behavior Modification Techniques

Self-monitoring Stimulus control Stress management Relapse prevention Social support

Page 29: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Pharmacotherapy

May be used as adjunctive therapy in BMI > 30 BMI > 27 + risk factors

Continue diet, physical activity and behavior therapy

Page 30: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Pharmacologic Interventions Agents approved for short term use only

Phentermine, diethylpropion, benzamphetamine

Increase NE in brain Usually prescribed 8-12 weeks Contraindications: hypertension, advanced

arteriosclerosis, cardiovascular disease, hyperthyroidism, glaucoma, agitated states, history of drug abuse, patients taking MAOI, tricyclic antidepressants

Page 31: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Pharmacologic Interventions Serotonergic Agents

Inhibits reuptake serotonin + NE + dopamine in brain

sibutramine (Meridia®); dosed once daily with or without food

Induces feeling of satiety Adverse effects include dry mouth, constipation,

headache, insomnia Contraindicated in cardiovascular disease, past

history of stroke Caution: Hypertension- monitor BP early

Page 32: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Pharmacologic Interventions

Pancreatic Lipase Inhibitor Blocks digestion of ~30% dietary fat orlistat (Xenical®); dosed 3 times daily

during or up to 1 hour after meal (with fat) GI side effects Can minimize GI side effects with a low fat

(<30% fat) high fiber diet

Page 33: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Pharmacologic Interventions

OTC weight loss medications No FDA approved OTC ingredients Many products that claim to promote

weight loss Ephedra

Currently under FDA investigation Stimulant properties: potential to cause

increased blood pressure, MI, stroke, seizures, especially in high doses

Page 34: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Surgery

Reserved for patients in whom other treatments have failed AND who have clinically severe obesity

Page 35: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Now what do you do?

Behavioral approaches: Develop a therapeutic relationship Determine patient readiness Partner with patient / facilitate “buddies”

Goal: Increase energy expenditure through planned and unplanned physical activity and decrease energy intake

Page 36: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Three levels of management

Level I Entry level Educate patients re:

health risks of obesity and health benefits of increased physical activity and weight

loss

Distribute literature Offer Digi-Walkers®, exercise bands, etc. Get to know the weight loss drugs & community

resources very well

Page 37: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Three levels of management

Level II Add all or some of the following: Medical quality scale and height tape/bar Assess health risks: BMI and waist circumference Referral relationships w/ other providers Incorporate weight management strategies into

disease management programs (e.g. HTN/DM) Documentation system Marketing

Page 38: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Three levels of management

Level III Health-oriented weight loss and physical activity

improvement as a focal point of pharmacy practice Pharmacist is facilitator, motivator, educator Dedicated assessment room and classroom Program fee: primarily private pay Small group or individual counseling Marketing of screenings and classes

Page 39: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Useful Resources

www.nhlbi.nih.gov/about/oei/Obesity Education Initiative

www.obesity.orgAmerican Obesity Association

www.d.umn.edu/student/loon/soc/phys/par-q.htmlPhysical Activity Readiness Questionnaire (PAR-Q)

Page 40: Physical Activity and Weight Management Julie Hagel, Pharm.D. September 24, 2003.

Conclusion

Obesity is recognized as a disease Obesity and lack of physical activity

present significant health risks Few providers are involved in weight

management A screening and management program

is a viable pharmacy practice option